Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SANOFI INDIA LTD.

NSE : SANOFIBSE : 500674ISIN CODE : INE058A01010Industry : Pharmaceuticals & DrugsHouse : Sanofi India - MNC

BSE3180.5526.75 (+0.85 %)

PREV CLOSE ( ) 3153.80

OPEN PRICE ( ) 3179.05

BID PRICE (QTY) 3174.00 (1)

OFFER PRICE (QTY) 3177.90 (7)

VOLUME 743

TODAY'S LOW / HIGH ( )3173.35 3225.00

52 WK LOW / HIGH ( )3057.6 6399.95

NSE3176.8025 (+0.79 %)

PREV CLOSE( ) 3151.80

OPEN PRICE ( ) 3175.00

BID PRICE (QTY) 3175.90 (5)

OFFER PRICE (QTY) 3178.90 (1)

VOLUME 11003

TODAY'S LOW / HIGH( ) 3166.90 3232.30

52 WK LOW / HIGH ( )3054 6410

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 02-05 1956

Management Info

Rahul Bhatnagar - Chairman Deepak Arora - Managing Director

Registered Office

Address Sanofi House, C T S No. 117- B,L & T Business Park,Saki Vihar Road, Powai,
Mumbai,
Maharashtra-400072

Phone 022-2803 2000

Email igrc.sil@sanofi.com

Website www.sanofiindialtd.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

30Apr Sanofi India informs about press release
In accordance with Regulation 30 of the SEBI (Listing Obligations and Di..

28Apr Appointment of Director
Inter alia, the Board of Directors have noted/approved the following: a..

28Apr Resignation of Director
Inter alia, the Board of Directors have noted/approved the following: a..

20Apr Sanofi India informs about board meeti
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosur..

28Feb Sanofi India informs about investor me
Sanofi India has informed that the Audio-Video recording of the Investor..

Financials

Rs. in Millions

	QTR Mar 26	ANNUAL 25
Net Profit	1026	3267
Gross Profit	1379	4447
Operating Profit	1472	5110
Net Sales	4723	18374

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Kwality Pharma (BSE) 2498.25 (6.93%)	M.Cap ( in Cr)2592.23
Abbott India (BSE) 26250.00 (0.40%)	M.Cap ( in Cr)55811.29
Venus Remedies (BSE) 1682.35 (5.00%)	M.Cap ( in Cr)2248.80
Concord Biotech (BSE) 1345.00 (5.78%)	M.Cap ( in Cr)14069.31
Caplin Point Lab (BSE) 2329.80 (3.20%)	M.Cap ( in Cr)17748.73

Shareholding Pattern

	PROMOTERS	60.4%
	NON-INSTITUTION	12.83%
	FI/BANKS/INSURANCE	11.86%
	MUTUAL FUNDS/UTI	9.26%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Baroda BNP Paribas ...	1.98
Nippon India Pharma...	1.71
PGIM India Healthca...	1.65
Aditya Birla SL Pha...	1.46
Baroda BNP Paribas ...	1.21
Baroda BNP Paribas ...	1.18
SBI Midcap Fund-Reg(G)	1.15

Risk Disclosures on Derivatives

Smart Quotes

SANOFI INDIA LTD.